BluePrint is an 80‑gene molecular subtyping assay designed to evaluate the functional pathways driving tumor biology, rather than individual gene mutations or receptor presence alone.

Those 80 genes collectively assess activity across three key biological programs:

Together, BluePrint and MammaPrint gene signatures represent and capture all 10 Hallmarks of Cancer.⁷